Healthcare provider profile · identity verified

Jacob Paul Meyer

Family Practice · GREEN BAY, WI · NPI 1922528801

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	526	152
Omeprazole	Omeprazole	310	89
Rosuvastatin Calcium	Rosuvastatin Calcium	270	71
Simvastatin	Simvastatin	236	70
Losartan Potassium	Losartan Potassium	228	63
Lisinopril	Lisinopril	206	63
Levothyroxine Sodium	Levothyroxine Sodium	199	44
Tamsulosin Hcl	Tamsulosin Hcl	198	56
Gabapentin	Gabapentin	185	46
Furosemide	Furosemide	184	42
Jardiance	Empagliflozin	177	33
Metformin Hcl	Metformin Hcl	171	51
Amlodipine Besylate	Amlodipine Besylate	150	45
Metoprolol Succinate	Metoprolol Succinate	150	46
Pantoprazole Sodium	Pantoprazole Sodium	145	42
Metformin Hcl Er	Metformin Hcl	143	38
Metoprolol Tartrate	Metoprolol Tartrate	105	33
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	102	31
Sertraline Hcl	Sertraline Hcl	100	32
Ozempic	Semaglutide	93	18
Eliquis	Apixaban	88	26
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	88	26
Pravastatin Sodium	Pravastatin Sodium	87	26
Trulicity	Dulaglutide	83	16
Trazodone Hcl	Trazodone Hcl	76	23
Alprazolam	Alprazolam	75	22
Albuterol Sulfate Hfa	Albuterol Sulfate	74	37
Allopurinol	Allopurinol	67	21
Mounjaro	Tirzepatide	67	12
Potassium Chloride	Potassium Chloride	66	18
Spironolactone	Spironolactone	63	15
Hydrochlorothiazide	Hydrochlorothiazide	61	19
Montelukast Sodium	Montelukast Sodium	61	16
Fluticasone Propionate	Fluticasone Propionate	59	24
Buspirone Hcl	Buspirone Hcl	56	suppressed
Duloxetine Hcl	Duloxetine Hcl	56	16
Pioglitazone Hcl	Pioglitazone Hcl	53	19
Pregabalin	Pregabalin	53	15
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	49	11
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	48	15
Mirtazapine	Mirtazapine	46	11
Olmesartan Medoxomil	Olmesartan Medoxomil	46	17
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	45	suppressed
Finasteride	Finasteride	44	suppressed
Baclofen	Baclofen	43	suppressed
Carvedilol	Carvedilol	43	12
Clonazepam	Clonazepam	43	11
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	43	14
Escitalopram Oxalate	Escitalopram Oxalate	41	suppressed
Oxycodone Hcl	Oxycodone Hcl	40	suppressed
Diclofenac Sodium	Diclofenac Sodium	39	17
Tramadol Hcl	Tramadol Hcl	38	12
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	37	14
Citalopram Hbr	Citalopram Hydrobromide	36	13
Quetiapine Fumarate	Quetiapine Fumarate	36	11
Zolpidem Tartrate	Zolpidem Tartrate	35	suppressed
Lorazepam	Lorazepam	33	16
Triamcinolone Acetonide	Triamcinolone Acetonide	33	22
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	32	29
Ezetimibe	Ezetimibe	32	12
Prednisone	Prednisone	31	17
Celecoxib	Celecoxib	29	suppressed
Lovastatin	Lovastatin	29	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	29	11
Xarelto	Rivaroxaban	29	suppressed
Clopidogrel	Clopidogrel Bisulfate	27	suppressed
Enalapril Maleate	Enalapril Maleate	27	suppressed
Donepezil Hcl	Donepezil Hcl	26	suppressed
Lamotrigine	Lamotrigine	26	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	25	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	25	11
Glipizide Er	Glipizide	25	suppressed
Meloxicam	Meloxicam	25	suppressed
Myrbetriq	Mirabegron	25	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	24	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	24	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	24	suppressed
Terazosin Hcl	Terazosin Hcl	23	suppressed
Torsemide	Torsemide	23	suppressed
Alendronate Sodium	Alendronate Sodium	22	suppressed
Atenolol	Atenolol	22	suppressed
Tizanidine Hcl	Tizanidine Hcl	22	suppressed
Bupropion Xl	Bupropion Hcl	21	suppressed
Ketoconazole	Ketoconazole	20	15
Chlorthalidone	Chlorthalidone	19	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	19	suppressed
Easy Touch Alcohol Prep Pads	Alcohol Antiseptic Pads	19	suppressed
Fenofibrate	Fenofibrate	19	suppressed
Januvia	Sitagliptin Phosphate	19	suppressed
Latanoprost	Latanoprost	19	suppressed
Paroxetine Hcl	Paroxetine Hcl	19	suppressed
Symbicort	Budesonide/Formoterol Fumarate	19	suppressed
Azithromycin	Azithromycin	18	suppressed
Diazepam	Diazepam	18	suppressed
Fenofibrate	Fenofibrate,micronized	18	suppressed
Glipizide	Glipizide	18	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	18	suppressed
Warfarin Sodium	Warfarin Sodium	18	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	17	suppressed
Ipratropium Bromide	Ipratropium Bromide	16	suppressed
Levetiracetam	Levetiracetam	16	suppressed
Valacyclovir	Valacyclovir Hcl	16	suppressed
Midodrine Hcl	Midodrine Hcl	15	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	15	11
Ondansetron Hcl	Ondansetron Hcl	15	suppressed
Bupropion Hcl Sr	Bupropion Hcl	14	suppressed
Glimepiride	Glimepiride	14	suppressed
Irbesartan	Irbesartan	14	suppressed
Ropinirole Hcl	Ropinirole Hcl	14	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	13	suppressed
Darifenacin Er	Darifenacin Hydrobromide	13	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	13	suppressed
Hydrocortisone	Hydrocortisone	13	suppressed
Naltrexone Hcl	Naltrexone Hcl	13	suppressed
Sucralfate	Sucralfate	13	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	13	12
Aripiprazole	Aripiprazole	12	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	12	suppressed
Ibuprofen	Ibuprofen	12	suppressed
Lidocaine	Lidocaine	12	suppressed
Linzess	Linaclotide	12	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	12	suppressed
Amoxicillin	Amoxicillin	11	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error